Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Divi's Laboratories Ltd

+ Add to Watchlist

DIVI:IN

1,739.15 INR 50.65 3.00%

As of 06:05:48 ET on 01/28/2015.

Snapshot for Divi's Laboratories Ltd (DIVI)

Open: 1,694.85 Day's Range: 1,685.15 - 1,744.00 Volume: 291,978
Previous Close: 1,688.50 52wk Range: 1,210.00 - 1,888.05 1-Yr Rtn: +36.62%

Stock Chart for DIVI

No chart data available.
  • DIVI:IN 1,739.15
  • 1D
  • 1M
  • 1Y
1,688.50
Interactive DIVI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DIVI

Current P/E Ratio (ttm) 29.8515
Estimated P/E(03/2015) 26.2197
Relative P/E vs. SENSEX 1.4540
Earnings Per Share (INR) (ttm) 58.2600
Est. EPS (INR) (03/2015) 66.3300
Est. PEG Ratio -
Market Cap (M INR) 230,844.84
Shares Outstanding (M) 132.73
30 Day Average Volume 139,504
Price/Book (mrq) 7.7900
Price/Sale (ttm) 9.1411
Dividend Indicated Gross Yield 1.15%
Cash Dividend (INR) 20.0000
Dividend Ex-Date 07/31/2014
5 Year Dividend Growth 46.14%
Next Earnings Announcement 01/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DIVI

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for DIVI

Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.

Murali Krishna Prasad DiviChairman/Managing DirectorN V RamanaExecutive Director
L Kishore BabuChief Financial OfficerRamesh Babu M G SChief Technologist
More Company Profile & Key Executives for DIVI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil